Skip to main content

Table 3 Quality appraisal of included studies using Newcastle-Ottawa Scale

From: A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections

Study (Author-Date)

Representativeness

Demonstration that outcome not present at outset

Assessment of outcome (proven infection vs suspected infection based on other criteria)

Adequacy of follow-up (<5% loss)

Alleyne 2000 [31]

*

*

*

*

Arabi 2005 [36]

*

  

*

Bota 2005 [35]

*

*

*

*

Camacho 2011 [8]

*

*

 

*

Chi 2009 [24]

*

*

*

*

Dasic 2006 [10]

*

 

*

*

Fichtner 2010 [28]

*

*

 

Hader 2000 [17]

*

*

*

*

Hoefnagel 2008 [2]

*

*

*

 

Holloway 1996 [25]

  

*

Khalil 2005 [9]

*

*

*

*

Kim 2012 [34]

*

*

*

*

Kitchen 2011 [6]

  

*

*

Lemcke 2012 [20]

*

*

*

*

Leverstein Van-Dall 2010 [21]

*

  

*

Lo 2007 [18]

*

*

 

*

Lundberg 2000 [16]

*

*

 

Lwin 2012 [27]

*

 

*

*

Lyke 2001 [13]

*

*

*

*

Mahe 1995 [7]

*

  

*

McLaughlin 2012 [19]

   

*

Moon 2007 [12]

*

 

*

*

Park 2004 [29]

*

*

*

*

Rafiq 2011 [15]

*

*

*

*

Rivero-Garvia 2011 [26]

*

  

*

Roitberg 2001 [30]

  

*

Scheithauer 2009 [23]

*

*

 

*

Scheithauer 2010 [22]

*

*

 

*

Schodel 2012 [32]

*

 

*

*

Schultz 1993 [11]

*

*

*

Sloffer 2005 [33]

 

*

*

*

Smigoc 2012 [5]

*

*

*

Smith 1976 [4]

*

 

*

 

Williams 2011 [14]

*

*

*

*

Wyler 1972 [3]

*

 

*

*

  1. *Denotes that the quality criteria has been met.